Search Result "proprotein convertase subtilisin/kexin type 9."
Natural Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Review
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 15 Year: 2023 Page: 2668-2678
Author(s):
The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1495-1499
Author(s): Konstantinos Tziomalos
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2013 Page: 281-288
Author(s): Maryna Popp Switzer,Azikiwe C. Nwosu,Zinnia San Juan,Debabrata Mukherjee
Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis
Journal: Current Drug Targets
Volume: 20 Issue: 10 Year: 2019 Page: 1029-1040
Author(s): Xinjie Lu
Proprotein Convertase Subtilisin/kexin type 9 Inhibition in Cardiovascular Prevention
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 4 Year: 2018 Page: 442-450
Author(s): Ali Ali,Pierluigi Costanzo,Angela Hoye
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review
Journal: Current Cardiology Reviews
Volume: 13 Issue: 4 Year: 2017 Page: 274-282
Author(s): Ahmad Hachem,Essa Hariri,Perla Saoud,Christelle Lteif,Louis Lteif,Francine Welty
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1403-1416
Author(s): Luca Liberale,Fabrizio Montecucco,Giovanni G. Camici,Franco Dallegri,Alessandra Vecchie,Federico Carbone,Aldo Bonaventura
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2016 Page: 94-100
Author(s): Muharrem Akin,Thomas Skripuletz,L. Christian Napp,Dominik Berliner,Ibrahim Akin,Arash Haghikia,Elvan Akin,Johann Bauersachs
Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R)
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2168-2182
Author(s): H. Palmer-Smith, A. Basak
The Lipid Hypothesis: From Resins to Proprotein Convertase Subtilisin/Kexin Type-9 Inhibitors
Ebook: Frontiers in Cardiovascular Drug Discovery
Volume: 5 Year: 2020
Author(s): Sudarshan Ramachandran,Mithun Bhartia,Carola S. König
Doi: 10.2174/9789811413247120050003